Cargando…

Leukemia-specific delivery of mutant NOTCH1 targeted therapy

On-target drug delivery remains a challenge in cancer precision medicine; it is difficult to deliver a targeted therapy to cancer cells without incurring toxicity to normal tissues. The SERCA (sarco-endoplasmic reticulum Ca(2+) ATPase) inhibitor thapsigargin inhibits mutant NOTCH1 receptors compared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roti, Giovanni, Qi, Jun, Kitara, Samuel, Sanchez-Martin, Marta, Saur Conway, Amy, Varca, Anthony C., Su, Angela, Wu, Lei, Kung, Andrew L., Ferrando, Adolfo A., Bradner, James E., Stegmaier, Kimberly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748843/ https://www.ncbi.nlm.nih.gov/pubmed/29158376 http://dx.doi.org/10.1084/jem.20151778

Ejemplares similares

Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
por: Pikman, Yana, et al.
Publicado: (2021)

New Approaches to Target T-ALL
por: Roti, Giovanni, et al.
Publicado: (2014)

Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
por: Baldoni, Stefano, et al.
Publicado: (2018)

Targeting Notch Trafficking and Processing in Cancers
por: Pagliaro, Luca, et al.
Publicado: (2020)

Targeting oncogenic Notch signaling with SERCA inhibitors
por: Pagliaro, Luca, et al.
Publicado: (2021)

Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
por: Sorrentino, Claudia, et al.
Publicado: (2019)

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
por: Fischer, Jacqueline, et al.
Publicado: (2023)

Genetic and proteomic approaches to identify cancer drug targets
por: Roti, G, et al.
Publicado: (2012)

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
por: Montanaro, Anna, et al.
Publicado: (2022)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

Targeting Csnk1a1 in leukemia
por: Stegmaier, Kimberly
Publicado: (2014)

Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia
por: Follini, Elena, et al.
Publicado: (2019)

Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
por: Aste-Amézaga, Miguel, et al.
Publicado: (2010)

Bilateral tonsillar infiltration of T‐cell prolymphocytic leukemia
por: Bertaggia, Ilaria, et al.
Publicado: (2019)

P410: COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA
por: Scheidegger, Nastassja, et al.
Publicado: (2023)

Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia
por: Chang, Yoon Soo, et al.
Publicado: (2023)

Notch Signaling in Acute Promyelocytic Leukemia
por: Grieselhuber, Nicole R., et al.
Publicado: (2013)

Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL
por: Sulis, Maria Luisa, et al.
Publicado: (2011)

Metabolic dependencies and vulnerabilities in leukemia
por: Rashkovan, Marissa, et al.
Publicado: (2019)

A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors
por: Sharma, Ankur, et al.
Publicado: (2015)

JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias
por: Kim, Sang-Kyu, et al.
Publicado: (2018)

Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition
por: Chen, Chong, et al.
Publicado: (2013)

CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia
por: González-García, Sara, et al.
Publicado: (2009)

CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia
por: González-García, Sara, et al.
Publicado: (2009)

Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia
por: Takam Kamga, Paul, et al.
Publicado: (2019)

Chemotactic Cues for NOTCH1-Dependent Leukemia
por: Piovan, Erich, et al.
Publicado: (2018)

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
por: Rosati, Emanuela, et al.
Publicado: (2018)

Biochemical Characterization and Cellular Effects of CADASIL Mutants of NOTCH3
por: Meng, He, et al.
Publicado: (2012)

Clonal evolution mechanisms in NT5C2 mutant relapsed acute lymphoblastic leukemia
por: Tzoneva, Gannie, et al.
Publicado: (2018)

Semi-Solid Pharmaceutical Formulations for the Delivery of Papain Nanoparticles
por: de Lima, Caroline S. A., et al.
Publicado: (2020)

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia
por: La Starza, Roberta, et al.
Publicado: (2019)

Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
por: Nabet, Behnam, et al.
Publicado: (2020)

The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia
por: Choi, Sung Hee, et al.
Publicado: (2017)

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
por: Pozzo, Federico, et al.
Publicado: (2022)

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
por: Sexauer, Amy N., et al.
Publicado: (2023)

High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling
por: Medyouf, Hind, et al.
Publicado: (2011)

Notch3 and its CADASIL mutants differentially regulate cellular phenotypes
por: Lin, Chunjing, et al.
Publicado: (2021)

The emerging roles of Notch signaling in leukemia and stem cells
por: Liu, Na, et al.
Publicado: (2013)

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
por: Baldoni, Stefano, et al.
Publicado: (2021)

Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer
por: de Lima, Caroline S. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_njar57bua3nes57jskta227h7k